Publications Office of the EU
Open-House-Verträge 2024-3 - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Open-House-Verträge 2024-3

Overview
  • Published
    16/08/2024
  • Today
    08/12/2024
  • Deadline
    29/10/2026
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
AOK Bremen/Bremerhaven
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DE501 Bremen, Kreisfreie Stadt
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
27
Procedure details
Tender reference number
2024-07-30-HB-DRA-Open House
Description

Open-House-Verträge für diverse Wirkstoffe bis 30.11.2026 bzw. 31.12.2025. Im Open House Verfahren sind Arzneimittel entsprechend der BfArM-Liste nach § 35 Abs. 5a SGB V (Kinderarzneimittel) ausgeschlossen.

Submission Method
Not available
Tenders may be submitted
Electronic submission: eu.europa.publications.PublicProcurement.electronic.submission.not-allowed
sp-of-eq
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
DE Deutschland
anyw-cou
CPV code

33600000 - Pharmaceutical products

Lots (27)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.